Your browser doesn't support javascript.
loading
Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma.
Fenk, R; Hoyer, B; Steidl, U; Kondakci, M; Graef, T; Heuk, R; Ruf, L; Strupp, C; Neumann, F; Rohr, U-P; Hildebrandt, B; Haas, R; Kobbe, G.
Leukemia ; 19(1): 156-9, 2005 Jan.
Article in En | MEDLINE | ID: mdl-15510204
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Multiple Myeloma / Antineoplastic Agents Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2005 Document type: Article Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Multiple Myeloma / Antineoplastic Agents Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2005 Document type: Article Country of publication: Reino Unido